NEU.AX - Neuren Pharmaceuticals Limited

ASX - ASX Delayed Price. Currency in AUD
Currency in AUD

Valuation Measures

Market Cap (intraday) 5321.81M
Enterprise Value 3286.99M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)281.30
Price/Book (mrq)287.27
Enterprise Value/Revenue 3250.86
Enterprise Value/EBITDA 6-31.53

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-802.27%

Management Effectiveness

Return on Assets (ttm)-106.52%
Return on Equity (ttm)-191.38%

Income Statement

Revenue (ttm)1.14M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-11.13M
Net Income Avi to Common (ttm)-8.19M
Diluted EPS (ttm)-0.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.27M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.53
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-7.55M
Levered Free Cash Flow (ttm)-5.32M

Trading Information

Stock Price History

Beta -1.29
52-Week Change 3165.00%
S&P500 52-Week Change 322.21%
52 Week High 33.50
52 Week Low 31.10
50-Day Moving Average 33.02
200-Day Moving Average 32.00

Share Statistics

Avg Vol (3 month) 3175.36k
Avg Vol (10 day) 3114.86k
Shares Outstanding 5101.84M
Float 56.38M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/20
Last Split Date 3Nov 21, 2017